Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: A review

References

• Applied Biosystems. 2005a. Cleavable ICAT reagents data sheet, (available at: http://www.appliedbiosystems.com, ) (accessed on 19 December 2005).
   Google Scholar
• Applied Biosystems. 2005b. ITRAQ reagents product bulletin (available at: http://www.appliedbiosystems.com, , ) (accessed on 19 December 2005).
   Google Scholar
• Barker CR, Hamlett J, Pennington SR, Burrows F, Lundgren K, Watson AJ, Jenkins JR. 2006. The topoisomerase II and Hsp90 interaction: a new chemotherapeutic target? International Journal of Cancer 118:2685–2693.
   PubMedGoogle Scholar
• Bradley EB, Bissonnette EA, Theodorescu D. Determinants of long term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer. British Journal of Urology International 2004; 94: 1003–1009
   Google Scholar
• Charaund P, Caprioloi RM. Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry. Electrophoresis 2002; 23: 3125–3135
   PubMedGoogle Scholar
• Clauser KR, Baker P, Burlingame AL. Role of accurate mass measurement (+/− 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Analytical Chemistry 1999; 71: 2871–2882
   PubMed Web of Science ®Google Scholar
• Conrads TP, Zhou M, Petricoin EF, Liotta L, Veenstra TD. Cancer diagnosis using proteomic patterns. Expert Reviews in Molecular Diagnosis 2003; 3: 411–420
   PubMed Web of Science ®Google Scholar
• Cutillas PR, Ckalkley RJ, Hansen KC, Cramer R, Norden AG, Waterfield MD, Burlingame AL, Unwin RJ. The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. American Journal of Physiology and Renal Physiology 2004; 287: 353–364
   PubMed Web of Science ®Google Scholar
• Duncan R, McConkey EH. How many proteins are there in the mammalian cell?. Clinical Chemistry 1982; 28: 749–755
   PubMed Web of Science ®Google Scholar
• Fenn JB, Mann M, Meng CK, et al. Electrospray ionisation for mass spectrometry of large biomolecules. Science 1989; 246: 64–71
   PubMed Web of Science ®Google Scholar
• Fernandez C, Rifai N, Wenger AS, et al. A preliminary study of urinary transferrin as a marker for prostate cancer. Clinica et Chimica Acta 1986; 161: 335–339
   PubMedGoogle Scholar
• Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FD, Walsh PC, Partin AW. Risk of prostate cancer specific mortality following biochemical recurrence after radical prostatectomy. Journal of the American Medical Association 2005; 294: 433–439
   PubMed Web of Science ®Google Scholar
• Fung KYC, Globe LM, Green S, et al. A comprehensive characterization of the peptide and protein constituents of human seminal fluid. Prostate 2004; 61: 171–181
   PubMed Web of Science ®Google Scholar
• Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004; 4: 3665–3685
   PubMed Web of Science ®Google Scholar
• Grover PK, Resnick MI. High resolution two dimensional electrophoresis analysis of urinary proteins of patients with prostate cancer. Electrophoresis 1997; 18: 814–818
   PubMedGoogle Scholar
• Hirsch J, Hansen KC, Burlingame AL. Proteomics: current techniques and potential applications to lung disease. American Journal of Physiology: Lung Cellular and Molecular Physiology 2004; 287: 1–23
   Web of Science ®Google Scholar
• Jenkins RE, Kitteringham NR, Hunter CL, Webb SN, Hunt TJ, Elsby R, Watson RB, Williams D, Pennington SR, Park K. 2005. Relative and absolute quantitative expression profiling of cytochromes P450 using isotope coded affinity tags. Proteomics 6:1934–1947.
   Google Scholar
• Jurcevic S, Ainsworth ME, Pomerance A, Smith JD, Robinson DR, Dunn MJ, Yacoub MH, Rose ML. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 2001; 71: 886–892
   PubMed Web of Science ®Google Scholar
• Karas M, Hillenkamp F. Laser desorption ionisation of proteins with molecular masses exceeding 10,000 Da. Analytical Chemistry 1988; 60: 2299–2301
   PubMed Web of Science ®Google Scholar
• Kuruma H, Egawa S, Oh-Ishi M, et al. Proteome analysis of prostate cancer. Prostate Cancer and Prostatic Diseases 2005; 8: 14–21
   PubMed Web of Science ®Google Scholar
• Mann M, Jensen ON. Proteomic analysis of post-translational modifications. National Biotechnology 2003; 21: 255–261
   Google Scholar
• Medzihradszky KF, Campbell JM, Baldwin MA, et al. The characteristics of peptide collision-induced dissociation using a high performance MALDI-TOF-TOF tandem mass spectrometer. Analytical Chemistry 2000; 72: 552–558
   PubMed Web of Science ®Google Scholar
• Merchant M, Weinberger SR. Recent advancements in SELDI-TOF-MS. Electrophoresis 2000; 21: 1164–1177
   PubMed Web of Science ®Google Scholar
• Mischak H, Kaiser T, Walder M, et al. Proteomic analysis for the assessment of diabetic renal damage in humans. Clinical Science 2004; 107: 485–495
   PubMed Web of Science ®Google Scholar
• Norden AG, Sharratt P, Cutillas PR, et al. Quantitative amino acid and proteomic analysis: very low excretion of polypeptides > 750 Da in normal urine. Kidney International 2004; 66: 1994–2003
   PubMed Web of Science ®Google Scholar
• Norden AGW, Scheinman SJ, Deschodt-Lanckman MM, et al. Tubular proteinuria defined by a study of Dents and other tubular diseases. Kidney International 2000; 57: 240–249
   PubMedGoogle Scholar
• O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. Journal of Biology and Chemistry 1975; 250: 4007–4021
   PubMed Web of Science ®Google Scholar
• Oh J, Pyo JH, Jo EH, et al. Establishment of a near standard two dimensional human urine proteomic map. Proteomics 2004; 4: 3485–3497
   PubMed Web of Science ®Google Scholar
• Pennington SR, Dunn MJ. Adding value in the target discovery and drug development pipeline (Part 1). European Pharmacology Review Issue 2003a; 1: 31–34
   Google Scholar
• Pennington SR, Dunn MJ. Adding value in the target discovery and drug development pipeline (Part 2). European Pharmacology Review Issue 2003b; 2: 16–19
   Google Scholar
• Pieper R, Gatlin CL, McGrath AM, et al. Characterization of the human urinary proteome: a method for high resolution display of urinary proteins on two dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004; 4: 1159–1174
   PubMed Web of Science ®Google Scholar
• Rehman I, Azzouzi R, Catto WF, et al. Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study. Journal of Urology 2004; 64: 1238–1243
   Google Scholar
• Rogers MA, Clarke P, Noble J, et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionisation and neural network analysis: identification of key issues affecting potential clinical utility. Cancer Research 2003; 63: 6971–6983
   PubMed Web of Science ®Google Scholar
• Schaub S, Rush D, Wilkins J, et al. Proteomic based detection of urine proteins associated with acute renal allograft rejection. Journal of the American Society of Nephrology 2004b; 15: 219–227
   PubMed Web of Science ®Google Scholar
• Schaub S, Wilkins J, Weiler T, et al. Urine protein profiling with surface enhanced laser-desorption/ionisation time of flight mass spectrometry. Kidney International 2004a; 65: 323–332
   PubMed Web of Science ®Google Scholar
• Schaub S, Wilkins JA, Antonovici M, et al. Proteomic based identification of cleaved urinary B2 microglobulin as a potential marker for acute tubular injury in renal allografts. American Journal of Transplantation 2005; 5: 729–738
   PubMed Web of Science ®Google Scholar
• Sharma K, Lee SH, Han S, et al. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 2005; 5: 2648–2655
   PubMed Web of Science ®Google Scholar
• Shekouh AR, Thompson CC, Prime W, Campbell F, Hamlett J, Herrington CS, Lemoine NR, Buechler MW, Friess H, Neoptolemo JP, Pennington SR, Costello E. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 2003; 3: 1988–2001
   PubMed Web of Science ®Google Scholar
• The National Cancer Registry Ireland. 2001. Incidence, mortality, treatment and survival 1994–2001 (available at: http://www.ncri.ie, , ) (accessed on 12 January 2006).
   Google Scholar
• The United Kingdom National Statistics. 2003. Mortality statistics for 2003 (available at: http://www.statistics.gov.uk, , ) (accessed on 12 January 2006).
   Google Scholar
• Thongboonkerd V, McLeish KR, Arthur JM, et al. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney International 2002; 62: 1462–1469
   Google Scholar
• Wittke S, Fliser D, Herbitz M, et al. Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. Journal of Chromatography 2003; A 1013: 173–181
   Google Scholar